116 related articles for article (PubMed ID: 25489255)
41. Cumulative cost pattern comparison of prostate cancer treatments.
Wilson LS; Tesoro R; Elkin EP; Sadetsky N; Broering JM; Latini DM; DuChane J; Mody RR; Carroll PR
Cancer; 2007 Feb; 109(3):518-27. PubMed ID: 17186528
[TBL] [Abstract][Full Text] [Related]
42. The mean attributable health care costs associated with hepatitis B virus in Ontario, Canada: A matched cohort study.
Nanwa N; Kwong JC; Feld JJ; Fangyun Wu C; Sander B
Can Liver J; 2022 Aug; 5(3):339-361. PubMed ID: 36133897
[TBL] [Abstract][Full Text] [Related]
43. Regional variation in the management of metastatic gastric cancer in Ontario.
Mahar AL; Coburn NG; Kagedan DJ; Viola R; Johnson AP
Curr Oncol; 2016 Aug; 23(4):250-7. PubMed ID: 27536175
[TBL] [Abstract][Full Text] [Related]
44. Cancer incidence, mortality, and stage at diagnosis in First Nations living in Manitoba.
Decker KM; Kliewer EV; Demers AA; Fradette K; Biswanger N; Musto G; Elias B; Turner D
Curr Oncol; 2016 Aug; 23(4):225-32. PubMed ID: 27536172
[TBL] [Abstract][Full Text] [Related]
45. Population-based utilization of radiation therapy by a Canadian breast cancer cohort.
Mittmann N; Seung SJ; Liu N; Porter J; Saskin R; Hoch JS; Evans WK; Leighl NB; Trudeau M; Earle CC
Curr Oncol; 2014 Oct; 21(5):e715-7. PubMed ID: 25302042
[TBL] [Abstract][Full Text] [Related]
46. Examination of Health System Resources and Costs Associated With Transitioning Cancer Survivors to Primary Care: A Propensity-Score-Matched Cohort Study.
Mittmann N; Beglaryan H; Liu N; Seung SJ; Rahman F; Gilbert J; De Rossi S; Earle CC; Grunfeld E; Zwicker V; LeBlanc D; Sussman J
J Oncol Pract; 2018 Oct; ():JOP1800275. PubMed ID: 30289736
[TBL] [Abstract][Full Text] [Related]
47. Utility of Contemporary Health Screening in the Diagnosis of Bladder Cancer.
Lee CU; Song W; Koo MJ; Boo Y; Chung JH; Kang M; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Jeong J; Jeon S
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626196
[TBL] [Abstract][Full Text] [Related]
48. Out-of-pocket payment and financial risk protection for breast cancer treatment: a prospective study from India.
Wadasadawala T; Mohanty SK; Sen S; Kanala TS; Maiti S; Puchali N; Gupta S; Sarin R; Parmar V
Lancet Reg Health Southeast Asia; 2024 May; 24():100346. PubMed ID: 38756158
[TBL] [Abstract][Full Text] [Related]
49. A mixed-method study evaluating an innovative care model for rural patients undergoing outpatient breast surgery.
Chiu S; Fowler S; Bridges S; Hanson N; King J; Street S; Tait H; Irving K; McLean P; McLaughlin L; Gulliver A
Can J Surg; 2024; 67(2):E77-E84. PubMed ID: 38453350
[TBL] [Abstract][Full Text] [Related]
50. Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020.
Seung SJ; Saherawala H; Moldaver D; Shokar S; Ammendolea C; Brezden-Masley C
Breast Cancer Res Treat; 2024 Apr; 204(2):341-357. PubMed ID: 38127177
[TBL] [Abstract][Full Text] [Related]
51. Factors affecting the economic burden of breast cancer in southern Iran.
Jalali FS; Seif M; Jafari A; Zangouri V; Keshavarz K; Ravangard R
BMC Health Serv Res; 2023 Dec; 23(1):1332. PubMed ID: 38041035
[TBL] [Abstract][Full Text] [Related]
52. Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy.
Williamson M; Press DJ; Hansen SA; Tomar A; Jhuti GS; Revil C; Gururaj K
Breast Cancer; 2024 Jan; 31(1):84-95. PubMed ID: 37907759
[TBL] [Abstract][Full Text] [Related]
53. Healthcare and Cancer Treatment Costs of Breast Screening Outcomes among Higher than Average Risk Women.
Mittmann N; Blackmore KM; Seung SJ; Diong C; Done SJ; Chiarelli AM
Curr Oncol; 2023 Sep; 30(9):8550-8562. PubMed ID: 37754535
[TBL] [Abstract][Full Text] [Related]
54. Capturing the True Cost of Breast Cancer Treatment: Molecular Subtype and Stage-Specific per-Case Activity-Based Costing.
Wilkinson AN; Seely JM; Rushton M; Williams P; Cordeiro E; Allard-Coutu A; Look Hong NJ; Moideen N; Robinson J; Renaud J; Mainprize JG; Yaffe MJ
Curr Oncol; 2023 Aug; 30(9):7860-7873. PubMed ID: 37754486
[TBL] [Abstract][Full Text] [Related]
55. Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data.
Baltz AP; Siegel ER; Kamal AH; Siegel R; Kozlik MM; Crist STS; Makhoul I;
JCO Oncol Pract; 2023 Feb; 19(2):e274-e285. PubMed ID: 36375114
[TBL] [Abstract][Full Text] [Related]
56. The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40-49 and 50-59.
Wilkinson AN; Billette JM; Ellison LF; Killip MA; Islam N; Seely JM
Curr Oncol; 2022 Aug; 29(8):5627-5643. PubMed ID: 36005182
[TBL] [Abstract][Full Text] [Related]
57. Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers.
Jannes M; König A; Kolben M; Fridrich C; Kirn V
Breast Care (Basel); 2022 Jun; 17(3):316-320. PubMed ID: 35957950
[TBL] [Abstract][Full Text] [Related]
58. Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy.
Climans SA; Grunfeld E; Mason WP; Chan KKW
Neuro Oncol; 2022 Oct; 24(10):1738-1748. PubMed ID: 35312784
[TBL] [Abstract][Full Text] [Related]
59. Cost of breast cancer diagnosis and treatment in India: a scoping review protocol.
Barathe PC; Haridas HT; Soni P; Kudiya KK; Krishnan JB; Dhyani VS; Rajendran A; Sirur AJN; Pundir P
BMJ Open; 2022 Mar; 12(3):e057008. PubMed ID: 35296485
[TBL] [Abstract][Full Text] [Related]
60. Overall Health Care Cost During the Year Following Diagnosis of Colorectal Cancer Stratified by History of Colorectal Evaluative Procedures.
Paszat L; Sutradhar R; Luo J; Rabeneck L; Tinmouth J; Baxter NN
J Can Assoc Gastroenterol; 2021 Dec; 4(6):274-283. PubMed ID: 34877466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
